Akari Therapeutics Plc (AKTX)
8.55
-0.22
(-2.51%)
USD |
NASDAQ |
Oct 12, 16:00
8.55
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Free Cash Flow (Quarterly) : -3.112M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.112M |
| March 31, 2026 | -2.484M |
| December 31, 2025 | -3.039M |
| September 30, 2025 | -2.102M |
| June 30, 2025 | -3.302M |
| March 31, 2025 | -2.15M |
| December 31, 2024 | -2.124M |
| September 30, 2024 | -1.49M |
| June 30, 2024 | -4.894M |
| March 31, 2024 | -4.044M |
| March 31, 2023 | -4.88M |
| June 30, 2022 | -8.574M |
| March 31, 2022 | -5.050M |
| December 31, 2021 | -5.004M |
| September 30, 2021 | -1.559M |
| June 30, 2021 | -4.866M |
| March 31, 2021 | -7.418M |
| December 31, 2020 | -4.233M |
| September 30, 2020 | -0.7042M |
| June 30, 2020 | -4.274M |
| March 31, 2020 | -7.740M |
| Date | Value |
|---|---|
| December 31, 2019 | -3.464M |
| September 30, 2019 | -4.910M |
| June 30, 2019 | -4.772M |
| March 31, 2019 | 0.2289M |
| December 31, 2018 | -4.567M |
| September 30, 2018 | -5.331M |
| June 30, 2018 | -8.284M |
| March 31, 2018 | -4.398M |
| December 31, 2017 | -8.517M |
| September 30, 2017 | -9.214M |
| June 30, 2017 | -4.73M |
| March 31, 2017 | -9.174M |
| December 31, 2016 | -6.395M |
| September 30, 2016 | -4.999M |
| June 30, 2016 | -6.080M |
| March 31, 2016 | -7.100M |
| December 31, 2015 | -6.768M |
| September 30, 2015 | 5.172M |
| June 30, 2015 | -1.316M |
| March 31, 2015 | -2.064M |
| December 31, 2013 | -4.198M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| DBV Technologies SA | -49.68M |
| Cellectis SA | -14.59M |
| Bicycle Therapeutics Plc | -49.96M |
| argenx SE | -- |
| Autolus Therapeutics Plc | -26.08M |